First lung cancer vaccine given to patient in international trial
A 67-year-old London man with lung cancer has been the first to receive a new cancer vaccine as part of an international trial. The early-stage research will test the immune therapy’s safety and whether it can be used together with existing cancer treatments.
Category: Health & Wellbeing, Lifestyle
Tags: Cancer, Lung cancer, Immunotherapy
Comentarios
Publicar un comentario